New drug combo before surgery may boost cancer fight
NCT ID NCT07507968
First seen Apr 04, 2026 · Last updated May 23, 2026 · Updated 8 times
Summary
This study tests giving a combination of chemotherapy and an immunotherapy drug (durvalumab) before surgery, followed by more durvalumab after surgery, for people with stomach or esophagus cancer that can be removed. The goal is to see if this approach leads to a complete disappearance of cancer cells in the removed tissue. About 101 adults with locally advanced cancer will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGOGASTRIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Caritas Klinikum Saabrücken
Saarbrücken, Germany
Contact
-
Charité Berlin
Berlin, Germany
Contact
-
HOPE Hamburg Eppendorf
Hamburg, Germany
Contact
-
Hospital Clínico Universitario de Valencia Servicio de Oncología Médica
Valencia, Spain
Contact
-
Hospital General Universitari Vall d'Hebron (HUVH)
Barcelona, Spain
Contact
-
Hospital Regional Universitario de Jaén
Jaén, Spain
Contact
-
Hospital Regional Universitario de Málaga
Málaga, Spain
Contact
-
Hospital Universitari Germans Trias i Pujol
Badalona, Spain
Contact
-
Hospital Universitario Central de Asturias. Oncología Médica
Oviedo, Spain
Contact
-
Hospital Universitario Miguel Servet Oncología Médica
Zaragoza, Spain
Contact
-
Hospital Universitario Virgen de las Nieves de Granada
Granada, Spain
Contact
-
Hospital Universitario de Navarra (HUN)
Pamplona, Spain
Contact
-
Klinikum Essen Mitte
Essen, Germany
Contact
-
Krankenhaus Nordwest
Frankfurt am Main, Germany
Contact
-
Marien Hospital Herne
Herne, Germany
Contact
-
NCT Heidelberg
Heidelberg, Germany
Contact
-
Nürnberg Klinikum Nord
Nuremberg, Germany
Contact
-
RKH Klinikum Ludwigsburg
Ludwigsburg, Germany
Contact
-
TU München
München, Germany
Contact
-
UKE Hamburg
Hamburg, Germany
Contact
-
Universitätsklinikum Halle (Saale)
Halle, Germany
Contact
-
Universitätsklinikum Köln
Cologne, Germany
Contact
-
Universitätsklinikum Leipzig
Leipzig, Germany
Contact
-
Universitätsklinikum Marburg
Marburg, Germany
Contact
-
Universitätsklinikum Ulm
Ulm, Germany
Contact
-
Universitätsmedizin Göttingen
Göttingen, Germany
Contact
-
Universitätsmedizin Mainz
Mainz, Germany
Contact
-
Universitätsmedizin Mannheim
Mannheim, Germany
Contact
-
Vivantes Klinikum Neukölln
Berlin, Germany
Contact
Conditions
Explore the condition pages connected to this study.